Impact on postmenopausal symptoms of adding continuous C-21 versus C-19 progestin to estrogen. [electronic resource]
Producer: 20000128Description: 153-61 p. digitalISSN:- 0378-5122
- Adverse Drug Reaction Reporting Systems
- Climacteric -- drug effects
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Drug Therapy, Combination
- Estrogen Replacement Therapy
- Female
- Humans
- Medroxyprogesterone Acetate -- administration & dosage
- Middle Aged
- Norgestrel -- administration & dosage
- Prospective Studies
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.